Neutral-Atom Platform Technologies
This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: • Fully programmable industry-ready quan…
Horizon Europe · European Union
Opens 10 Feb 2027
The EU's Horizon Europe programme expects to make 1 award of €3 million, from a total budget of €3 million. Applications close on 16 Sep 2027 (EU calls usually close at 17:00 Brussels time). Organisations in EU member states and Horizon Europe associated countries such as Türkiye can usually take part; the topic conditions control.
This action supports the follow-up to the July 2023 Communication on EU Missions assessment [1] . The successful proposal under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:
• Together, a network of registered cancer charities and funding agencies support transnational research and innovation projects on quality of life of children (age range 0-14, age at time of first diagnosis), adolescents (age range 15-19, age at time of first diagnosis) and young adults (age range 20-39, age at time of first diagnosis), cancer patients and survivors using their own financial resources.
• Projects supported by the network of charities and funding agencies will boost quality of life and long-term outcomes for young cancer patients and survivors, including improved physical, emotional, and social well-being.
• Researchers, innovators, and professionals from different disciplines and sectors ensure accessibility and re-usability of relevant digital data, to support the future UNCAN.eu research data platform, which is currently in preparation.
Due to significant investments in research and innovation, cancer survival rates in Europe have soared, with more than 12 million survivors, including 500,000 childhood cancer survivors. However, survivors, their families, and caregivers continue to face numerous challenges. Young cancer survivors, in particular, frequently suffer from long-term effects of treatment, including mental health issues like depression and anxiety, chronic pain, fatigue, cardiovascular complications, organ and skin changes, and infertility, all of which severely impact their quality of life.
Proposals should address all of the following:
• Together, registered cancer charities and funding agencies across EU Member States and Associated Countries, organise, fund and implement at least two transnational calls for proposals, resulting in grants to third parties to conduct research and innovation projects targeting quality of life of children (age range 0-14, age at time of first diagnosis), adolescents (age range 15-19, age at time of first diagnosis) and young adults (age range 20-39, age at time of first diagnosis) cancer patients and survivors. Grants should be awarded, not only in order of ranking but also to ensure that all three age groups are addressed.
• Organise regular networking activities between partners, as well as with representatives of successful projects, patients and patient organisations, citizens and stakeholders across EU Member States and Associated Countries to support the implementation of the action;
• Organise outreach campaigns at local, regional and national levels to raise awareness among different groups (citizens, patients and survivors, research communities, local, regional and national authorities etc.) about research and innovation projects funded through the transnational calls, including disseminating and exploiting research results. Where relevant, liaising with the National Cancer Mission Hubs which are in development through the ECHoS [2] project, should be considered.
Projects to be financed by charities and funding agencies through transnational calls for proposals are expected to:
• Develop, test and scale up in real-life settings innovative, holistic approaches and tools (including digital tools), optimising cancer treatment and follow-up regimens to improve the quality of life of young cancer patients and survivors.
• All datasets produced should be described with metadata records in the EU dataset catalogue of the European Health Data Space, while all tools and models should take advantage of current European research infrastructures, should follow the principles of open science and made available through the future UNCAN.eu platform.
• The chosen intervention(s) should be adapted to the specificities of the provision of care at local, regional, or national level, duly reflecting the diversity across EU Member States and Associated Countries.
• Projects should clearly benefit local communities of patients and survivors.
Under…
A single organisation from an EU Member State or associated country can apply (Horizon Europe standard rule).
Applicant categories are a starting point. The official call decides eligibility.
Child health Health inequalities Public health Quality of health care Rehabilitation Rights of the child National funders Philanthropy late-effects quality of life survivorship
Single-stage call. Next deadline 2027-09-16. The portal states the exact cut-off time (EU calls usually close at 17:00 Brussels time).
| Fact | Value | How we know | Taken from the source |
|---|---|---|---|
| Deadline | 16 September 2027 “Single-stage call. Next deadline 2027-09-16. The portal states the exact cut-off time (EU calls usually close at 17:00 Brussels time).” | official data field | 15 Nov 2026 |
| Amount per applicant | Unknown — not stated in the source we hold | unknown | — |
| Total budget | €3 million | official data field | 15 Nov 2026 |
| Funding rate | 100% of eligible costs | programme standard rule | 15 Nov 2026 |
| Who can apply | A single organisation from an EU Member State or associated country can apply (Horizon Europe standard rule). | programme standard rule | 15 Nov 2026 |
| Where to apply | Read the topic conditions on the EU Funding & Tenders Portal for eligible countries, consortium requirements, budget and the application route. | read from the official text | 15 Nov 2026 |
Facts on this page come from the funder’s official data, taken on 14 Nov 2026. The funder's own documents, including later amendments, always take precedence.
This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: • Fully programmable industry-ready quan…
This action will strengthen Europe's strategic autonomy in quantum-secure communications by advancing core QKD technologies and integration capabilities. Expected results…
This action will strengthen Europe's leadership and strategic autonomy in quantum technologies by advancing experimental pilot line capacities as a vital stepping stone t…
This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certificatio…
This action will consolidate Europe’s position in superconducting quantum computing through: • Establishment of a full-stack superconducting quantum computer aiming at 1.…